Two main factors behind Sanofi's dialog with Danish authorities
Of the six companies participating in the market consultation on vaccine production in Denmark, only Sanofi has an mRNA vaccine in development, which is what the Danish PM has called for. The French pharmaceutical giant does not agree to an interview, but relates that it has had a dialog with Danish authorities for two reasons.
by ulrich quistgaard, translated by nielsine nielsen
French life science giant Sanofi is one of three global companies interested in producing vaccines in Denmark as part of a tender organized by the Danish government and the Danish State Serum Institute (SSI).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Sanofi reveals detailed timeframe for RSV candidate
For subscribers
Bavarian Nordic: Vaccine production almost came to Denmark
For subscribers
